Grace Therapeutics Inc (GRCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 15,917 | 3,009 | 2,449 | 2,529 | 3,090 |
| Operating Income | -15,917 | -3,009 | -2,449 | -2,529 | -3,090 |
| Other Income | 127 | 131 | 134 | 1,591 | -272 |
| Pre-tax Income | -15,790 | -2,878 | -2,315 | -938 | -3,362 |
| Net Income Continuous | -15,790 | -1,178 | -2,315 | -938 | -3,362 |
| Net Income | $-15,790 | $-1,178 | $-2,315 | $-938 | $-3,362 |
| EPS Basic Total Ops | -0.91 | -0.06 | -0.14 | -0.06 | -0.21 |
| EPS Basic Continuous Ops | -0.91 | -0.07 | -0.14 | -0.06 | -0.21 |
| EPS Diluted Total Ops | -0.91 | -0.06 | -0.14 | -0.06 | -0.21 |
| EPS Diluted Continuous Ops | -0.91 | -0.07 | -0.14 | -0.06 | -0.21 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.07 | -0.14 | -0.15 | -0.21 |
| EBITDA(a) | $-15,915 | $-3,007 | $-2,446 | $-2,529 | $-3,088 |